A note on the inhibition of DT-diaphorase by dicoumarol

doi:10.1016/0891-5849(91)90191-5

Free Radical Biology and Medicine

Volume 11, Issue 1, 1991, Pages 77-80

https://doi.org/10.1016/0891-5849(91)90191-5 Get rights and content

Abstract

The participation of DT-diaphorase or NAD(P)H:(quinone acceptor) oxidoreductase (E.C.1.6.99.2) in metabolism or in events leading to toxicity is often implied on the basis of the inhibitory effects of dicoumarol. DT-diaphorase functions via a ping pong bi-bi kinetic mechanism involving oxidized and reduced flavin forms of the free enzyme. Dicoumarol, a potent (K₁ = 10 nM) inhibitor, binds to the oxidized form of the enzyme, competitively versus reduced pyridine nucleotide. Inhibition is effectively complete at 1 μM dicoumarol in typical studies using DCPIP, one of the best known substrate for the enzyme, as electron acceptor. The antitumor quinone Diaziquone (AZQ) is a poor substrate for DT-diaphorase relative to DCPIP, but effective inhibition of its reduction requires ten-fold higher concentrations of dicoumarol than for inhibition of DCPIP reduction under otherwise similar conditions. The variable inhibition of DT-diaphorase by dicoumarol dependent on the efficiency of the electron acceptor can be explained on the basis of the complete rate equation describing its ping pong type kinetic mechanism. Thus, the concentration of dicoumarol used to inhibit DT-diaphorase must be chosen carefully and consideration should be given to the efficiency of the electron acceptor. The absence of an inhibitory effect using low doses of dicoumarol cannot rule out a reaction mediated by DT-diaphorase. Although higher doses of dicoumarol may be required to inhibit DT-diaphorase mediated metabolism of less efficient electron acceptors, the use of such doses in cells may also effect biochemical processes other than DT-diaphorase and should be approached with caution.

References (31)

G. Powis et al.
Quinoneimines as substrates for quinone reductase (NAD)(P)H: (quinone-acceptor) oxidoreductase) and effect of dicumarol on their cytotoxicity
Biochem. Pharmacol.
(1987)
A. Brunmark et al.
DT-diaphorase catalyzed two-electron reduction of quinone epoxides
Free Radic. Biol. Med.
(1987)
L. Ernster et al.
Purification and some properties of a highly dicumarol sensitive liver diaphorase
Biochem. Biophys. Res. Commun.
(1960)
L. Ernster et al.
DT-diaphorase I: purification from the soluble fraction of rat liver cytoplasm and properties
Biochim. Biophys. Acta
(1962)
S. Hosoda et al.
Properties and reaction mechanism of DT-diaphorase from rat liver
J. Biol. Chem.
(1974)
P.M. Hollander et al.
Studies on the reaction mechanism of DT-diaphorase: intermediatry plateau and trough regions in the initial velocity versus substrate concentration curves
Arch. Biochem. Biophys.
(1975)
P.M. Hollander et al.
Studies on the reaction mechanism of DT-diaphorase. Action of dead-end inhibitors and effects of phospholipids
Arch. Biochem. Biophys.
(1975)
C. Lind et al.
DT-diaphorase as a quinone reductase. A cellular control device against semiquinone and superoxide radical formation
Arch. Biochem. Biophys.
(1982)
R.E. Talcott et al.
Possible role of DT-diaphorase in the bioactivation of antitumor quinones
Biochem. Biophys. Res. Commun.
(1983)
A. Begleiter et al.
Increased sensitivity of quinone-resistant cells to mitomycin C
Cancer Letters
(1989)

C. Martius et al.

Uber den wirkungsmechanismus des dicumarols und verwandter verbindungen

Biochem. Biophys. Acta

(1953)

M.J. Fasco et al.

Vitamin K1 hydroquinone formation catalyzed by DT-diaphorase

Biochem. Biophys. Res. Commun.

(1982)

W.W. Cleland

The kinetics of enzyme-catalyzed reactions with two or more substrates or products. II. Inhibition: Nomenclature- and theory

Biochim. Biophys. Acta

(1963)

L. Ernster

DT-diaphorase

Methods in Enzymol.

(1967)

A. Cornish-Bowden

Chapter 6. Two substrate reactions

Cited by (71)

Toward Ratiometric Detection of NAD(P)H Quinone Oxidoreductase-1: Benzocoumarin-Based Fluorescent Probes
2021, Sensors and Actuators, B: Chemical
NAD(P)H quinone oxidoreductase-1 (NQO1) plays a role in reducing free radicals in cells and in detoxification of xenobiotics. It is also associated with some cancers and chemoresistance. Therefore, noninvasive tools for studying the enzyme are in demand, leading to about 30 activatable fluorescent probes containing a quinone substrate so far. However, most of them detect the enzyme with turn-on signaling, as the quinone substrate is apt to quench fluorescence through photo-induced electron transfer. We disclose a rational approach to develop a ratiometric NQO1 probe, which explores fluorophores with mismatched orbital energies for the fluorescence quenching. Two NQO1 probes based on an in cellulo super-bright and a highly water-soluble, deep-red emitting benzocoumarin fluorophores were synthesized and evaluated: They detected the enzyme, affording bright turn-on and good ratiometric images, respectively, as observed by one-photon as well as two-photon microscopic imaging. From molecular modeling and kinetics studies, not the enzymatic reduction but the subsequent chemical conversion seems to govern the response time. The result validates our approach to develop a ratiometric fluorescent probe in case it contains a fluorescence-quenching substrate. Additionally, the two probes display environment-insensitive emission behavior and thus hold promise for studying the enzyme in biological systems, which are heterogeneous in nature.
Biomedical applications of 4-hydroxycoumarin as a fungal metabolite and its derivatives
2020, New and Future Developments in Microbial Biotechnology and Bioengineering: Recent Advances in Application of Fungi and Fungal Metabolites: Applications in Healthcare
4-Hydroxycoumarins came into the limelight when they caused internal bleeding to cattle in the United States and southern Canada. Warfarin, a coumarin derivative, was first used as a rodenticide and dramatically became an oral anticoagulant in the 1950s. These agents are natural fungal metabolites produced from coumarin, which is a precursor. These have been successfully used in medical conditions such as cardiac disease, pulmonary embolism, stroke, thrombophlebitis, etc., and derive big revenue in the pharmaceutical industry. After successful application as an anticoagulant, this class has been at the center of attention of various research groups across the globe. These are being proven to not only be nontoxic, economical, and ecofriendly, but also as sustainable agents. Current research trends show the great potential of this metabolite as an anticancer, antiarthritic, antipyretic, and antimicrobial agent. This chapter will discuss the present-day application of 4-hydroxycoumarins and the enormous potential it holds for the future.
A resorufin-based fluorescent turn-on probe responsive to nitroreductase activity and its application to bacterial detection
2019, Dyes and Pigments
We present two resorufin-based fluorescent turn-on probes responsive to nitroreductase (NTR) activity (NTR probes 1 and 2) and their use toward the detection of bacteria. The probes exhibit a fluorescence turn-on at 586 nm in response to NTR activity, which corresponds to a vivid pink color. These optical changes are based on the NTR-mediated reduction of the nitro groups in the probes, which results in the production of highly fluorescent resorufin. The detection ability, mechanism, and enzyme kinetics of the probes for NTR activity have been thoroughly investigated. The enzyme efficiencies of the probes were superior to those previously reported. In addition, NTR probe 1 exhibited an excellent detection ability for NTR with high selectivity and no background signal when compared to 2. Moreover, NTR probe 1 was applicable for bacterial detection using a wash-free process because it gave rise to a fluorescence turn-on signal in response to bacterial NTR activity.
Excited state hydrogen atom transfer in micro-solvated dicoumarol: A TDDFT/EFP1 study
2019, Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
Citation Excerpt :
Hydroxy coumarins have been exploring for their optical applications; laser dyes, fluorophores, chromophores, colorants [68–71] and biological applications; anticarcinogens, antifungals, spasmolytic and sun-screening additives, and enzyme inhibitors [72–75]. Dicoumarol is a 4HC derived naturally occurring anticoagulant, acts as a potent inhibitor of NAD(P)H: quinone oxidoreductase 1 (NQO1), binds to the oxidized form of the enzymes and affects the growth of tumor cells [62–64]. Dicoumarol treatment to human myeloid leukemia HL-60 cells increases the superoxide levels, essential for inhibition of G0/1 blockade [65].
Ground (S₀) and excited (S₁) state properties of dicoumarol (DC) are investigated by applying density functional theory (DFT) and time dependent DFT (TDDFT) interfacing with the effective fragment potential (EFP) method of solvation. Benzene and pyrone rings of the each 4-hydroxy coumarin (4HC) moiety are in a plane and these planes are twisted by 180° with respect to each other. Two intra-molecular hydrogen bonds (HB) CO⋯HO exist between the carbonyl (CO) and hydroxyl (OH) groups of different 4HC moieties (4HC-1 and 4HC-2). DC(H₂O)₃ complex is formed using the original EFP model (EFP1). Four inter-molecular HBs are established by the carbonyl and hydroxyl oxygen atoms of 4HC-1 and 4HC-2 moieties; two HBs with two solvent molecules on one side of the complex and other two HBs with one solvent molecule at the other side. In S₁ state, the hydrogen atomtransfer takes place only from the hydroxyl group of 4HC-1 to the carbonyl group of 4HC-2. The natural charge analysis and the modification of HBs manifest the intra-molecular charge transfer (ICT) from one 4HC moiety to another. Theoretical and experimental studies of the absorption spectra, and the theoretical study of potential energy curves of OH bonds at both S₀ and S₁ states affirm the hydrogen atom transfer from the hydroxyl group of 4HC-1 to the carbonyl group of 4HC-2 moiety.
An improved cell-permeable fluorogenic substrate as the basis for a highly sensitive test for NAD(P)H quinone oxidoreductase 1 (NQO1) in living cells
2018, Free Radical Biology and Medicine
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a flavoenzyme upregulated in response to oxidative stress and in some cancers. Its upregulation by compounds has been used as an indicator of their potential anti-cancer properties. In this study we have designed, produced and tested a fluorogenic coumarin conjugate which selectively releases highly fluorescent 4-methylumbelliferone (4-MU) in the presence of NQO1. It was found that measuring 4-MU release rapidly and specifically quantitated NQO1 levels in vitro and in live cells. Both the substrate and its products freely perfused through cell membranes and were non-toxic. The substrate was very specific with low background, and the assay itself could be done in less than 10 minutes. This is the first assay to allow the quantitation of NQO1 in live cells which can then be retained for further experiments.
Distinct responses of compartmentalized glutathione redox potentials to pharmacologic quinones targeting NQO1
2017, Biochemical and Biophysical Research Communications
Citation Excerpt :
Therefore, we next asked to what extent NQO1 contributes to these unique responses by monitoring real-time alterations of EGSH in the presence of NQO1 inhibitors. To gain further insight into the mechanism of mitochondrial DNQ response, A549 cells were incubated with dicumarol, a potent inhibitor of NQO1 [24]. The DNQ-induced oxidative response of the cytosolic probe was fully abolished in dicumarol-treated cells as evidenced by an unchanged 395/494 nm excitation ratio near 0.1 both before and after challenge with DNQ (Fig. 1A″), confirming the cytosolic NQO1 enzyme is a major target for DNQ in A549 cells.
Deoxynyboquinone (DNQ), a potent novel quinone-based antineoplastic agent, selectively kills solid cancers with overexpressed cytosolic NAD(P)H:quinone oxidoreductase-1 (NQO1) via excessive ROS production. A genetically encoded redox-sensitive probe was used to monitor intraorganellar glutathione redox potentials (E_GSH) as a direct indicator of cellular oxidative stress following chemotherapeutic administration. Beta-lapachone (β-lap) and DNQ-induced spatiotemporal redox responses were monitored in human lung A549 and pancreatic MIA-PaCa-2 adenocarcinoma cells incubated with or without dicumarol and ES936, potent NQO1 inhibitors. Immediate oxidation of E_GSH in both the cytosol and mitochondrial matrix was observed in response to DNQ and β-lap. The DNQ-induced cytosolic oxidation was fully prevented with NQO1 inhibition, whereas mitochondrial oxidation in A549 was NQO1-independent in contrast to MIA-PaCa-2 cells. However, at pharmacologic concentrations of β-lap both quinone-based substrates directly oxidized the redox probe, a possible sign of off-target reactivity with cellular thiols. Together, these data provide new evidence that DNQ's direct and discerning NQO1 substrate specificity underlies its pharmacologic potency, while β-lap elicits off-target responses at its effective doses.